Varenne Capital Partners »

Horizon Therapeutics shares owned by Varenne Capital Partners

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Varenne Capital Partners from 13F filings

Historical chart of Varenne Capital Partners investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Varenne Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Varenne Capital Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $8.1M 70k 115.69
2023-06-30 $5.8M 57k 102.85
2023-03-31 $4.3M 39k 109.14

More positions owned by Varenne Capital Partners

Ubs Group Call Call Option (UBS)
Qiagen Nv Shs New
Activision Blizzard
Horizon Therapeutics Pub L SHS
National Instruments
Fortrea Hldgs Common Stock (FTRE)
Heritage-Crystal Clean
Learn Cw Investment Cor Cl A Ord Shs (LCW)

View all positions for Varenne Capital Partners

Top funds holding Horizon Therapeutics

IFP Advisors
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics